Debra Hovanec-Burns

Title: Debra Hovanec-Burns: Innovator in Human Insulin-Like Growth Factor Research

Introduction

Debra Hovanec-Burns is a notable inventor based in Wappingers Falls, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of human insulin-like growth factor binding proteins. Her work has implications for various medical applications, showcasing her innovative spirit and dedication to advancing healthcare.

Latest Patents

Debra holds a patent for a non-recombinant human insulin-like growth factor binding protein concentrate. This patent describes a human insulin-like growth factor (IGF) binding protein stock solution and a method of making the same. The solution includes a non-recombinant human IGF binding protein-3 (nr-IGFBP-3) in an aqueous buffered medium. The concentration of the nr-IGFBP-3 in the stock solution ranges from about 16 micrograms per milliliter (μg/ml) to about 40 μg/ml. Additionally, a kit is included that features a set of calibrators for nr-IGFBP-3, which contains the nr-IGFBP-3 in different concentrations. This innovation is crucial for research and clinical applications involving IGF binding proteins.

Career Highlights

Debra is currently employed at Siemens Healthcare Diagnostics GmbH, where she continues to contribute to advancements in healthcare diagnostics. Her role at Siemens allows her to collaborate with other professionals in the field, enhancing her impact on medical technology.

Collaborations

Some of her coworkers include Ryan Spears and Spencer Lin, who work alongside her in the pursuit of innovative solutions in healthcare diagnostics. Their collaboration fosters a dynamic environment for research and development.

Conclusion

Debra Hovanec-Burns exemplifies the spirit of innovation in the biotechnology sector. Her contributions, particularly in the realm of human insulin-like growth factor binding proteins, highlight her commitment to improving healthcare outcomes.